StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) stock

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Karyopharm Therapeutics's ebitda for the twelve months ending Sep 30, 2020 was -$177.09M. For fiscal 2019 it was -$188.30M. The highest annual figure on record is -$10.23M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2019Dec 31, 2019-$188.30M–
FY2018Dec 31, 2018-$179.15M–
FY2017Dec 31, 2017-$129.83M–
FY2016Dec 31, 2016-$110.02M–
FY2015Dec 31, 2015-$118.44M–
FY2014Dec 31, 2014-$75.52M–
FY2013Dec 31, 2013-$33.81M–
FY2012Dec 31, 2012-$15.77M–
FY2011Dec 31, 2011-$10.23M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020-$46.87M–
Q2 FY2020Jun 30, 2020-$40.08M–
Q1 FY2020Mar 31, 2020-$47.11M–
Q4 FY2019Dec 31, 2019-$43.02M–
Q3 FY2019Sep 30, 2019-$39.16M–
Q2 FY2019Jun 30, 2019-$41.44M–
Q1 FY2019Mar 31, 2019-$64.68M–
Q4 FY2018Dec 31, 2018-$57.26M–
Q3 FY2018Sep 30, 2018-$48.97M–
Q2 FY2018Jun 30, 2018-$34.15M–
Q1 FY2018Mar 31, 2018-$38.77M–
Q4 FY2017Dec 31, 2017-$39.28M–
Q3 FY2017Sep 30, 2017-$30.88M–
Q2 FY2017Jun 30, 2017-$29.57M–
Q1 FY2017Mar 31, 2017-$30.10M–
Q4 FY2016Dec 31, 2016-$26.99M–
Q3 FY2016Sep 30, 2016-$25.56M–

More Karyopharm Therapeutics figures

See a number that looks wrong?